Glomerular hyperfiltration and albuminuria are two pathological conditions that could alter renal drug elimination, but they have been rarely studied in a critical care setting.
Historically, the study of renal function in critically ill patients has focussed on renal failure [1] [2] [3] . Drug dosages administered to these patients are reduced according to the degree of renal deterioration, in order to avoid accumulation of the drug and consequent toxicity 4 . For all intents and purposes, renal function is synonymous with glomerular filtration rate (GFR) 5 and is usually classified into the following categories: normal (GFR >90 ml/min/1.73 m 2 ), reduced (between 60 and 90 ml/min/1.73 m 2 ) or corresponding to chronic kidney disease (<60 ml/min/1.73 m 2 ) 6 .
Nonetheless, GFR may be elevated in certain conditions, a situation also known as glomerular hyperfiltration (GHF) [7] [8] [9] [10] . GHF may occur not only in chronic illnesses such as diabetes mellitus, essential hypertension or obesity, but also in physiological situations such as pregnancy. In the case of pregnancy, GHF is attributed to the hyperdynamic circulatory state, which leads to increased cardiac output and consequent elevation in renal blood flow 11 . Some critically ill patients may also present a hyperdynamic circulatory situation as manifested by an elevated cardiac index 12 , indicating potential GHF and ensuing increase in renal clearance of substances, including drugs 13, 14 .
On the other hand, a systemic inflammatory response syndrome may occur secondary to severe trauma, a condition leading to generalised increase in capillary permeability manifested at the renal glomerular level by the presence of urinary albumin 15, 16 . Logically, drugs bound to albumin may also escape into the urine.
Regarding drug dosing, the two different pathophysiological mechanisms previously described share the same outcome: both could increase renal capacity for elimination of drugs, implying risk of underdosing. However, as far as we know there is no study addressing the issue of GHF in critically ill patients. The main objective of this study is to determine rates of GHF in critically ill patients. Secondary aims are to ascertain the percentage of patients presenting with albuminuria and whether this condition is associated with GHF.
MATERIALS AND METHODS

Basic study design
This is an observational, prospective study of a cohort of adult patients of both genders admitted to the reanimation unit of the University General Hospital of Albacete (Spain), where critical as well as intermediate care is provided. Exclusion criteria were: age under 18 years, declining participation in study, not having a bladder catheter in place or requiring haemodialysis techniques during their stay in the reanimation unit.
As already mentioned, there is no study addressing the issue of GHF in critically ill patients, but creatinine clearance (CrCl) values in the range of GHF can be identified in some works reporting individual CrCl values (GHF of 10% to 15%) 17, 18 . Sample size (89 patients) was calculated based on these works by estimating a conservative 10% incidence of renal hyperfiltration. Patients were selected sequentially until calculated sample size was met. The study was approved by our Hospital Ethics Committee and biological samples were collected with informed consent from each patient or patient's family members.
Study variables and methods
On admission, the following variables were collected for each patient: demographic data (age, gender, weight, height), pre-existing comorbid conditions (diabetes mellitus, arterial hypertension, cardiac or renal disease) and main reason for admission divided into three categories (multiple trauma, surgical pathology or medical pathology). Additionally, throughout the week following admission, a daily timed urine sample was collected by means of a bladder catheter during a four-hour period starting at 0700 hours. During urine collection, a 5 ml blood sample was also obtained in a dry tube via an arterial catheter or a central venous line and five hourly measurements of blood pressure were performed. Fluid therapy and previous 24 hour diuresis were recorded as well as the administration of frusemide or inotropes (noradrenaline or adrenaline) before and during sampling.
Creatinine concentrations in plasma and urine were determined using a kinetic modification of the Jaffé reaction, and those of urinary microalbumin via a turbidimetric endpoint method, on an Olympus AU 640 analyser.
CrCl was used as indicator of the GFR, the latter routinely measured in clinical practice and calculated by applying the customary formula. CrCl levels above 120 ml/min/1.73 m 2 were considered as GHF 19 .
Proteinuria was expressed as the albumincreatinine ratio (ACR) and was classified according to the following categories specified by the National Kidney Foundation (NKF): ACR values below 20 mg/g were considered normal, while those above 20 mg/g were indicative of albuminuria. In turn, albuminuria was broken down into two further categories: microalbuminuria with ACR values between 20 and 300 mg/g and clinical proteinuria indicated by ACR values above 300 mg/g 20 .
Statistical analysis
The descriptive analysis was undertaken using the habitual measures of central tendency and dispersion (mean and standard deviation, or the median and range). For the bivariable analysis, the Student's t-test was used for parametric variables and the Mann-Whitney U-test for non-parametric variables. In order to compare proportions, Fisher's exact test and the likelihood ratio chi-square were applied. A significance level of P <0.05 was chosen for all statistics employed.
All analyses were performed using SPSS 11.0 software (SPSS Inc., Chicago, IL, USA).
RESULTS
General characteristics
The characteristics of the 89 patients included in this study are summarised in Table 1 and principal diagnoses or type of surgery prompting admission to the reanimation unit are shown in Table 2 .
Age distribution according to reason for admission indicated that multiple trauma patients were significantly younger (37.5±16.8 years) than subjects admitted postoperatively (63.7±15.5 years) or due to medical pathologies (66.1±20.4 years) (P <0.0001).
Admission frequency of patients with hypertension or diabetes mellitus, pathologies commonly associated with GHF or albuminuria, was not particularly elevated in our study (Table 1 ). However, amongst those subjects presenting with either one of these two pathologies, rates of albuminuria were very high (92% [n=23] in the hypertensive group and 85.7% [n=12] amongst diabetics). In comparison, frequency of GHF presentation in these two groups of patients was relatively low (16% [n=4] amongst hypertensives and none in the diabetic category).
During the first day of admission, none of the subjects received frusemide. Between the second and fourth days, five patients began treatment with frusemide for a total of seven accumulated days. Ten patients were given noradrenaline on the first day of the study, amongst which four required additional days of treatment: two for one extra day, one received another round of treatment on days five and six and one subject was treated throughout the seven days of the study.
On admission, 25 patients were on mechanical ventilation (28%) and for the remaining days of the study the rates were 13 (31%), eight (33%), 10 (53%), three (23%), three (30%) and three (30%) for the rest of the days.
There were eight patient deaths (8.9%) during the stay at the unit, consisting of two postoperative cases, three multiple trauma cases and three patients with medical pathologies. The course of the remaining patients was not followed after discharge or transfer from the reanimation unit.
Glomerular hyperfiltration
Sixteen patients presented with GHF (17.9%; CI 95% 10.5 to 26.5) the first morning of admission to the reanimation unit, with mean CrCl levels of 142±17 ml/min/1.73 m 2 and minimum/maximum values of 121 and 195 ml/min/1.73 m 2 respectively (Figure 1 ). Obviously, compared to the GHF group, mean CrCl levels were considerably lower in non-GHF patients [71±30] (Figure 2) , with a range of values from 3 to 118 ml/min/1.73 m 2 . Urology (7) Number of patients presenting with each pathology is shown in parentheses. Table 1 , GHF patients were characterised by being significantly younger, with greater body surface area, higher diastolic blood pressure and diuresis levels, lower APACHE II scores on admission and, additionally, demonstrated a clear trend towards higher mean blood pressure than their non-GHF counterparts. While the number of patients remaining in the unit declined during the one-week study period, the percentage showing GHF increased markedly throughout this time (Figure 1 ).
As shown in
Albuminuria
Seventy-five percent of patients presented with albuminuria the first morning of admission to the reanimation unit (67% microalbuminuria and 8% clinical proteinuria). These patients were significantly older and had obtained poorer APACHE II scores on admission (Table 1) . Elevated rates of albuminuria persisted throughout the week of the study, irrespective of the number of patients remaining in the unit (Figure 3 ).
Relationship between glomerular hyperfiltration and albuminuria
There were no statistically significant associations (P=0.153) between presentation of GHF (CrCl >120 ml/min/1.73 m 2 ) and albuminuria (albumincreatinine ratio >20 mg/g) ( Table 3) .
DISCUSSION
In this exploratory study, we found that both glomerular hyperfiltration and albuminuria are relatively frequent conditions in critically ill patients. 
Glomerular hyperfiltration
Our results showed that 17.9% of patients presented with GHF the first morning of their stay in the reanimation unit, with rates increasing throughout the week of the study. We do not believe that these higher than expected rates of GHF were biased by comorbid conditions likely to lead to hyperfiltration, since none of the diabetic patients and only four of the hypertensive patients presented with GHF. Besides, several patients with normal glomerular filtration rate at the time of admission developed GHF over time (Figure 1) . In our opinion, these findings could be explained by changes in the patient's condition. The studies of Pea et al 12 or Conil et al 13 reveal that the critically ill patient may develop a hyperdynamic/hyperkinetic state, leading to increased CrCl and renal elimination of drugs. Since we did not measure cardiac output in this study, we cannot state that an increase in this parameter causes GHF. However, our results showed a trend toward higher values of mean blood pressure and significantly higher values of diastolic blood pressure in GHF patients, important physiological factors in renal perfusion.
There was a peak in CrCl on the fifth day following admission, coinciding with previous descriptions in a trial by Brown et al 21 . Brown suggested their finding may have been due to a compensation mechanism following adequate fluid administration during reanimation procedures of the preceding days, indicating initiation of haemodynamic equilibrium and recuperation. We support this explanation, although similar future studies measuring both cardiac output and renal blood flow would be necessary to confirm the theory.
Until now, GHF has assumed only scant clinical significance in critical care patients, possibly due to the fact that GHF is a concept normally employed in the study of chronic pathologies 10 . The workup of acute pathology, on the other hand, is dominated by analysis of renal failure. It is notable that in previous studies in which we were able to identify individual CrCl values above 120 ml/min/1.73 m 2 , this finding remains either unmentioned 17, 18 or only commented upon in the context of reduced renal function in acute patients. None of these studies insist on the significance that high CrCl values could have with respect to drug dosing 13, 14, 21 .
Furthermore, the reference interval for CrCl is wide 22 and the defining criterion of GHF is not firmly established 7-10 ; in fact, NKF criteria do not set an upper limit of normality for GFR which could be used as a reference 6 . Therefore, we followed the proposal of Sunder-Plassmann et al 19 for defining normal GFR and GHF in our study. If we start from the range of values which define low GFR (CrCl=60 to 90 ml/min/1.73 m 2 ) according to the NKF categorisation 6 , and add intervals of 30 ml/min/1.73 m 2 to these values, then normal intervals can be defined as 90 to 120 ml/min/1.73 m 2 . Consequently, a CrCl higher than 120 ml/min/1.73 m 2 would be considered GHF according to this formula. We are conscious of the fact that this categorisation receives no significant bibliographic support, but it appeared useful for undertaking our first exploratory work.
Another clear limitation of our study is that categories of GFR were not defined according to age groups. For example, it is obvious that a CrCl value of 115 ml/min/1.73m 2 does not have the same physiological significance in a 30-year-old patient as it would have for a 70-year-old one 10 . Lastly, this study is based on morning urine samples collected during four-hour periods rather than 24-hour timed urine collections. Our method may raise objections, given that results could be influenced by chronobiological factors pertaining to diurnal variations in CrCl. However, the brief timed urine collection method has the advantage of minimising errors related to sample collection, it can be carried out daily and allows early reevaluation of drug dosages to adapt to unexpected clinical changes with less delay than the 24-hour urine collection 18, 23 . Furthermore, some studies of critical patients and normal subjects have shown CrCl values calculated from brief urine collection periods to be useful and well-correlated with those obtained by 24-hour urine collection 18, 21, [24] [25] [26] .
Even taking the above-mentioned limitations into account, and leaving aside the definition of GHF, we consider it useful to study the repercussions that elevated GFR may have upon drug dosing in critical patients, specifically risk of underdosing due to improved elimination of drugs. In fact, several studies involving critically ill patients show close correlations between CrCl and elimination of piperacillin 13 , cefepime 27 or cefpirome 28 .
Albuminuria
Our results show an elevated frequency of patients presenting with albuminuria, especially microalbuminuria, both on admission and during the week of the study in the unit (Table 3 and Figure 3 ).
With specific reference to critical trauma 15 or critical postoperative patients 29 , the glomerular disturbance leading to microalbuminuria is caused by a stress-induced systemic inflammatory response syndrome resulting in capillary leakage which allows small amounts of albumin to escape into the urine. This transcapillary loss of albumin seems to be a major cause of the hypoalbuminemia seen in various acute conditions 30 . Albuminuria was significantly associated with poorer APACHE II scores and with older patients, suggesting that the condition manifests itself in aged kidneys exposed to severe insult. On the other hand, the GHF profile corresponded to healthy kidneys exposed to less severe insults.
With respect to drug dosing, we speculate that the capillary leakage of albumin may be directly implicated in the process of elimination of medications, since many drugs attach themselves to plasma proteins, mainly albumin. Therefore the hypothesis to be tested in cases of albuminuria is whether the fraction of the drug attached to plasma albumin is also lost in the urine, converting this into an alternative route of drug elimination which may have repercussions on drug dosing, especially in cases of clinical proteinuria.
Relationship between glomerular hyperfiltration and albuminuria
We failed to find a clear association between glomerular hyperfiltration and albuminuria; similar results have been found in diabetes type 2 patients 10 . We believe that this is due to the different pathophysiological origins of each of these phenomena. The glomerular capillaries must be intact in order to clear substances from the plasma: the more their integrity is compromised by deterioration and alteration of permeability, the more the resulting glomerular filtrate will resemble plasma in its composition. Therefore, the possibility of finding elevated CrCl values diminishes with increasing degree of permeability of the glomerular capillaries. Consequently, it appears congruent that we found only a relatively small number of albuminuria patients who also showed GHF (12.7%) ( Table 3) . Of the 22 patients in this study without albuminuria, 31.8% presented with GHF, presumably related to haemodynamic factors independent of those leading to the condition of albuminuria. This assumption, however, must be taken with caution since the reduced sample size limits the power of the current study; future research is needed to confirm our suppositions.
CONCLUSIONS
In this first exploratory study, we found that both glomerular hyperfiltration and albuminuria are frequent conditions in critically ill patients. Further studies are required in order to understand the clinical impact of these phenomena upon elimination of drugs and their ideal dosing in such cases.
